Tag: Co-Diagnostics

CoPrimers™ used in proof of concept evaluation SALT LAKE CITY--(BUSINESS WIRE)-- Co-Diagnostics, Inc. (NASDAQ: CODX), a diagnostics company with a unique, ...

CODX updates on initial six months as a public company SALT LAKE CITY--(BUSINESS WIRE)-- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics ...

Project moving forward on schedule, with production to begin in Q3 2018 SALT LAKE CITY--(BUSINESS WIRE)-- Co-Diagnostics, Inc. (NASDAQ: CODX), a ...

SALT LAKE CITY--(BUSINESS WIRE)-- Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company with a unique, proprietary platform ...

Laboratory will meet CGMP Requirements of FDA; Will be BSL-2 to allow enhanced in-house verification and validation activities SALT LAKE ...

Sep.11.17 | About: Co-Diagnostics (CODX)  The following slide deck was published by Co-Diagnostics in conjunction with this event. https://seekingalpha.com/article/4105790-co-diagnostics-codx-presents-24th-annual-newsmakers-biotech-industry-slideshow

Audit to prepare for eventual sales into the US market SALT LAKE CITY--CODX, (BUSINESS WIRE)-- Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or ...